Loading clinical trials...

Sildenafil IV Bolus Study | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT00800592

Sildenafil IV Bolus Study

The objective of this study is to assess the safety, tolerability and pharmacokinetics of intravenous sildenafil (10 mg) administered as a bolus injection to patients with Pulmonary Arterial Hypertens...

Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

NCT06814145 · Hypertension, Pulmonary

RECRUITINGNA

A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension

NCT07079592 · Artificial Intelligence (AI), Artificial Intelligence (AI) in Diagnosis, and more

RECRUITINGNA

Functional Pulmonary Capillary Surface Area in BPA for CTEPH

NCT05719415 · Hypertension, Pulmonary, Pulmonary Thromboembolisms

RECRUITING

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires

NCT01501838 · Hypertension, Pulmonary Arterial

RECRUITING

Real-World Study of PADN for the Treatment of PAH

NCT07039604 · Pulmonary Hypertension, Hypertension, Pulmonary Arterial

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 1, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment12

Start dateOct 2008

Last updatedFeb 1, 2021

Condition

Hypertension, Pulmonary

Locations shown

Pfizer Investigational Site

Brussels

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 1, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions